RT info:eu-repo/semantics/article
T1 Prognostic role of TAPSE to PASP ratio in patients undergoing MitraClip procedure
A1 Trejo Velasco, Blanca
A1 Estevez Loureiro, Rodrigo
A1 Carrasco Chinchilla, Fernando
A1 Fernández Vázque, Felipe
A1 Arzamendi, Dabit
A1 Pan, Manuel
A1 Pascual, Isaac
A1 Nombela Franco, Luis
A1 Amat Santos, Ignacio Jesús
A1 Freixa, Xavier
A1 Hernández Antolín, Rosa Ana
A1 Trillo Nouche, Ramiro
A1 Andraka Ikazuriaga, Leire
A1 López Mínguez, José R.
A1 Sanmiguel Cervera, Dario
A1 Sanchis, Juan
A1 Diez Gil, José Luis
A1 Ruiz Quevedo, Valeriano
A1 Urbano Carrillo, Cristóbal
A1 Becerra Muñoz, Víctor Manuel
A1 Benito González, Tomás
A1 Li, Chi Hion
A1 Mesa, Dolores
A1 Avanzas, Pablo
A1 Armijo, Germán
A1 Serrador Frutos, Ana María
A1 Sanchis, Laura
A1 Fernández-Golfín Lobán, Covadonga
A1 Cid Álvarez, Belén
A1 Hernández García, José María
A1 Garrote Coloma, Carmen
A1 Fernández Peregrina, Estefanía
A1 Romero, Miguel
A1 León Arguero, Víctor
A1 Cruz González, Ignacio
K1 Cardiac surgery
K1 Cardiology
K1 Corazón - Cirugía
K1 Pulmonary hypertension
K1 Hipertensión pulmonar
K1 Echocardiography
K1 Mitral valve - Diseases - Imaging
K1 Heart valves - Diseases - diagnostic imaging
K1 Heart - Diseases
K1 Corazón - Enfermedades
K1 3205.01 Cardiología
K1 3207.04 Patología Cardiovascular
AB Background: Transcatheter mitral valve repair (TMVR) is an effective therapy for high-risk patients with severe mitral regurgitation (MR) but heart failure (HF) readmissions and death remain substantial on mid-term follow-up. Recently, right ventricular (RV) to pulmonary arterial (PA) coupling has emerged as a relevant prognostic predictor in HF. In this study, we aimed to assess the prognostic value of tricuspid annular plane systolic excursion (TAPSE) to PA systolic pressure (PASP) ratio as a non-invasive measure of RV-to-PA coupling in patients undergoing TMVR with MitraClip (Abbott, CA, USA). Methods: Multicentre registry including 228 consecutive patients that underwent successful TMVR with MitraClip. The sample was divided in two groups according to TAPSE/PASP median value: 0.35. The primary combined endpoint encompassed HF readmissions and all-cause mortality. Results: Mean age was 72.5 ± 11.5 years and 154 (67.5%) patients were male. HF readmissions and all-cause mortality were more frequent in patients with TAPSE/PASP ≤ 0.35: Log-Rank 8.844, p = 0.003. On Cox regression, TAPSE/PASP emerged as a prognostic predictor of the primary combined endpoint, together with STS-Score. TAPSE/PASP was a better prognostic predictor than either TAPSE or PASP separately. Conclusions: TAPSE/PASP ratio appears as a novel prognostic predictor in patients undergoing MitraClip implantation that might improve risk stratification and candidate selection.
SN 2077-0383
YR 2021
FD 2021
LK https://uvadoc.uva.es/handle/10324/59993
UL https://uvadoc.uva.es/handle/10324/59993
LA eng
NO Journal of Clinical Medicine, 2021, Vol. 10, Nº. 5, 1006
NO Producción Científica
DS UVaDOC
RD 24-nov-2024